Building on Record Setting 2023
Camber launched 33 new generic products in 2023. Our portfolio now has over 150 generic products, with over 600 SKUs, across numerous therapeutic areas and formulation types. Watch our short video (96 seconds) highlighting major accomplishments from 2023!
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection
